BMO Capital Markets Cuts Prestige Consumer Healthcare (NYSE:PBH) Price Target to $117.00
Prestige Consumer Healthcare (NYSE:PBH – Free Report) had its target price trimmed by BMO Capital Markets from $124.00 to $117.00 in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other brokerages also recently commented on PBH. StockNews.com downgraded shares of Prestige Consumer Healthcare […]
More Stories
Ilhan Omar, Broken Vetting, and Minnesota’s Billion-Dollar Fraud: The Questions That Will Not Die
By Stephen Zogopoulos, USNN World News The federal investigation into Rep. Ilhan Omar’s immigration history and the massive public-benefits fraud...
Democrats Sue Trump Admin Over Bid to Clean Up Voter Rolls
By Zachary Stieber Senate Minority Leader Chuck Schumer (D-N.Y.) and other Democrats have sued the Trump administration over its effort...
Implementing Freight Management Software: In-House or With Specialist Help?
You’ve picked a freight platform. Now you have to get it live without stopping trucks, missing invoices or losing track...
DOGE Illegally Accessed Data on Government Workers: Judge
By Zachary Stieber A federal judge ruled on Oct. 20 that a department aimed at making the government more efficient...
UK Rearrests 2 Men Over Suspected Terror Plot at Air Base
By Jill McLaughlin UK police have rearrested two men, suspected of working for Iran’s intelligence service, for allegedly plotting to...
$245 Million Taxpayer-Backed Loan to Fund Naval Shipbuilding Facilities
By AAP Australia will lend hundreds of millions of dollars to the nation’s largest shipbuilder for a massive new manufacturing...